Initial Statement of Beneficial Ownership (3)
October 01 2019 - 4:12PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Jafry Syed A. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/1/2019
|
3. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [TMO]
|
(Last)
(First)
(Middle)
168 THIRD AVENUE |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Sr. Vice President / |
(Street)
WALTHAM, MA 02451
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 15037 | D | |
Common Stock | 41.32 | I | by 401K |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (Right to Buy) | (1) | 2/24/2023 | Common Stock | 5638 | $129.77 | D | |
Stock Option (Right to Buy) | (2) | 2/28/2024 | Common Stock | 12400 | $157.68 | D | |
Stock Option (Right to Buy) | (3) | 2/27/2025 | Common Stock | 13725 | $210.68 | D | |
Stock Option (Right to Buy) | (4) | 2/26/2026 | Common Stock | 16400 | $253.99 | D | |
Explanation of Responses: |
(1) | The option vests in four equal annual installments beginning on February 24, 2017. |
(2) | The option vests in four equal annual installments beginning on February 28, 2018. |
(3) | The option vests in four equal annual installments beginning on February 27, 2019. |
(4) | The option vests in four equal annual installments beginning on February 26, 2020. |
Remarks: Exhibit List: Exhibit 24 - Confirming Statement |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Jafry Syed A. 168 THIRD AVENUE WALTHAM, MA 02451 |
|
| Sr. Vice President |
|
Signatures
|
/s/ Melodie T. Morin, Attorney-in-Fact for Syed A. Jafry | | 10/1/2019 |
**Signature of Reporting Person | Date |
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Sep 2023 to Sep 2024